Cargando…

Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke

PURPOSE: To identify the most important factors affecting physician decision-making regarding antiplatelet therapy. METHODS: We retrospectively gathered data from minor ischemic stroke patients with NIHSS scores ≤ 5 within 72 h of onset from 2010 to 2018. The population was divided into four groups...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tingting, Li, Yanan, Niu, Xiaoyuan, Wang, Yongle, Zhang, Kaili, Fan, Haimei, Ren, Jing, Li, Juan, Fang, Yalan, Li, Xinyi, Wu, Xuemei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477012/ https://www.ncbi.nlm.nih.gov/pubmed/36119700 http://dx.doi.org/10.3389/fneur.2022.937417

Ejemplares similares

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Evaluation of the association between admission systolic blood pressure and the choice of initial antiplatelet therapy for minor ischemic stroke in real‐world
por: Liu, Tingting, et al.
Publicado: (2022)

Dual versus mono antiplatelet therapy in mild‐to‐moderate stroke during hospitalization
por: Fan, Haimei, et al.
Publicado: (2022)

Triglyceride-glucose index, symptomatic intracranial artery stenosis and recurrence risk in minor stroke patients with hypertension
por: Wang, Yongle, et al.
Publicado: (2023)

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
por: Ye, Fei, et al.
Publicado: (2021)

Elevated stress hyperglycemia and the presence of intracranial artery stenosis increase the risk of recurrent stroke
por: Wang, Yongle, et al.
Publicado: (2023)

Dual Antiplatelet Therapy in Patients With Minor Stroke Receiving Intravenous Thrombolysis
por: Xu, Zhaohan, et al.
Publicado: (2022)

Serum neurofilament light chain levels are associated with early neurological deterioration in minor ischemic stroke
por: Li, Jie, et al.
Publicado: (2023)

Editorial: Challenges in Acute Minor Ischemic Stroke
por: Heldner, Mirjam R., et al.
Publicado: (2022)

The Impact of Cerebral Microbleeds Presence on Outcome Following Minor Stroke Treated With Antiplatelet Therapy
por: Sakuta, Kenichi, et al.
Publicado: (2020)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

Comparison of the Characteristics and Risk Factors of Carotid Atherosclerosis in High Stroke Risk Populations Between Urban and Rural Areas in North China
por: Zhang, Jin, et al.
Publicado: (2020)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

Treatment Challenges in Acute Minor Ischemic Stroke
por: Slawski, Diana, et al.
Publicado: (2021)

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis
por: Liu, Tingting, et al.
Publicado: (2023)

Time-Based Decision Making for Reperfusion in Acute Ischemic Stroke
por: Grøan, Mathias, et al.
Publicado: (2021)

Personalised antiplatelet therapy based on pharmacogenomics in acute ischaemic minor stroke and transient ischaemic attack: study protocol for a randomised controlled trial
por: Zhang, Xiao-Guang, et al.
Publicado: (2019)

Comparing the Effectiveness of Intravenous Tissue Plasminogen Activator and Dual Antiplatelet Therapy in Patients With Minor Stroke: A Meta-Analysis
por: Monday, Obinna, et al.
Publicado: (2023)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
por: Khazaal, Ossama, et al.
Publicado: (2021)

Longitudinal Brain Atrophy Rates in Transient Ischemic Attack and Minor Ischemic Stroke Patients and Cognitive Profiles
por: Munir, Muhammad, et al.
Publicado: (2019)

The Association Between Heart Rate Variability and 90-Day Prognosis in Patients With Transient Ischemic Attack and Minor Stroke
por: Li, Changhong, et al.
Publicado: (2021)

Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East
por: Naveed, Hiba, et al.
Publicado: (2023)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience
por: Lin, Sheng-Feng, et al.
Publicado: (2021)

An overview of the evidence to guide decision-making in acupuncture therapies for early recovery after acute ischemic stroke
por: Wang, Liuding, et al.
Publicado: (2022)

Antiplatelet Resistance and Thromboembolic Complications in Neurointerventional Procedures
por: Oxley, Thomas J., et al.
Publicado: (2011)

Lasting impairments following transient ischemic attack and minor stroke: a systematic review protocol
por: Hede Ebbesen, Birgitte, et al.
Publicado: (2023)

Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Long-Term Cerebrovascular Outcomes in Patients With Minor Stroke or Transient Ischemic Attack
por: Zhang, Xiao-Guang, et al.
Publicado: (2021)

Altered Functional Connectivity and Cognition Persists 4 Years After a Transient Ischemic Attack or Minor Stroke
por: Nicolas, Korinne, et al.
Publicado: (2021)

Large Vessel Occlusion in Patients With Minor Ischemic Stroke in a Population-Based Study. The Dijon Stroke Registry
por: Duloquin, Gauthier, et al.
Publicado: (2022)

Intra-Arterial Thrombolysis Vs. Mechanical Thrombectomy in Acute Minor Ischemic Stroke Due to Large Vessel Occlusion
por: Sun, Dapeng, et al.
Publicado: (2022)

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
por: Niu, Peng-Peng, et al.
Publicado: (2016)

Echocardiographic correlates of MRI imaging markers of cerebral small-vessel disease in patients with atrial-fibrillation-related ischemic stroke
por: Ye, Kaili, et al.
Publicado: (2023)

The Impact of Preinjury Use of Antiplatelet Drugs on Outcomes of Traumatic Brain Injury: A Systematic Review and Meta-Analysis
por: Cheng, Li, et al.
Publicado: (2022)

The Characteristics of Patients With Possible Transient Ischemic Attack and Minor Stroke in the Hunter and Manning Valley Regions, Australia (the INSIST Study)
por: Tomari, Shinya, et al.
Publicado: (2020)

Machine Learning-Based Model for Prediction of Hemorrhage Transformation in Acute Ischemic Stroke After Alteplase
por: Xu, Yanan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_knbl2t8fvmurjc417som9hhc6m